Helena Deus (@hdeus) 's Twitter Profile
Helena Deus

@hdeus

Curing Cancer by organizing information; advocating for FAIR data & unbiased AI; Learning leadership lessons by sailing. At EPAM Systems. My posts are my own.

ID: 20617750

linkhttp://bit.ly/helena-deus calendar_today11-02-2009 19:29:30

948 Tweet

580 Followers

831 Following

Helena Deus (@hdeus) 's Twitter Profile Photo

Clear evidence for #bias in #AI . Hard to tell how many engineers use DistilBERT but it has 60K stars and 14K forks in github, a sign that it is used in decision making by probably > 100K developers.

Helena Deus (@hdeus) 's Twitter Profile Photo

Hi Twitter followers - on the 7th May I am going to climb a lot of stairs to raise funds for Leukemia in honor of those that I have lost. Will you help me fund them? pages.lls.org/bigclimb/home/…

Helena Deus (@hdeus) 's Twitter Profile Photo

Inspiring video from my employer! Life sciences R&D excellence from ZS: Helping pharma leaders innovate youtu.be/oudqStaI_vk via YouTube

Pedro Domingos (@pmddomingos) 's Twitter Profile Photo

Backpropagation was invented by a psychologist trying to understand how children learn language. Who knows where the next world-sweeping ML algorithm will come from?

Helena Deus (@hdeus) 's Twitter Profile Photo

#zsassociates talk on data operations to bring together science and technology in R&D data management to start in 2 minutes in room 209 #BioIT22 OR #bioit

Helena Deus (@hdeus) 's Twitter Profile Photo

If only medical care would move forward and consider the health of all human beings, imagine what we could accomplish as a species!

Prof. Nikolai Slavov (@slavov_n) 's Twitter Profile Photo

In 2015, an article in @nature estimated that 800,000,000 USD is wasted annually on nonspecific antibodies. It also suggested standardization, which has not happened. I wonder how much we will spend in 2023 on low specificity antibodies.

In 2015, an article in @nature estimated that 800,000,000 USD is wasted annually on nonspecific antibodies.

It also suggested standardization, which has not happened. I wonder how much we will spend in 2023 on low specificity antibodies.